Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$16.9M | -$45.8M | -$86.1M | -$149M | -$280M | -$414M |
| Net income | -$14.6M | -$46.3M | -$81.9M | -$126M | -$261M | -$425M |
| EPS (diluted) | -$5.08 | -$2.13 | -$1.65 | -$2.17 | -$3.93 | -$5.85 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.9M | -$40.0M | -$65.0M | -$99.7M | -$185M | -$275M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.3M | $68.5M | $242M | $335M | $146M | $262M |
| Total assets | $10.6M | $294M | $482M | $732M | $1.14B | $1.41B |
| Total liabilities | $6.62M | $8.79M | $19.5M | $31.8M | $72.0M | $164M |
| Shareholders' equity | -$31.3M | $285M | $463M | $701M | $1.07B | $1.25B |
| Retained earnings | -$31.9M | -$78.2M | -$160M | -$286M | -$547M | -$972M |
| Shares (wtd avg diluted) | 2.87M | 21.8M | 49.7M | 58.2M | 66.4M | 72.7M |
Every figure is extracted from Nuvalent, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.